Who are the most active healthcare CIOs on Twitter?
Since the first edition of the Huffington Post’s most active chief information officers on Twitter, healthcare leadership execs have stepped up to the plate to increase their online presence. Today, healthcare CIOs account for 8 percent of the Post’s 100 most social CIOs on Twitter; ranging from diverse specialties: IT officials, nonprofit gurus and healthcare systems officials, who have joined the online marketplace of healthcare activity.
This increased online presence should not come as a surprise to healthcare professionals, due to the need for virtual marketing and constant social media interaction. It has proven to be just as important as presenting a quality product and service, because if no one is talking about you, then who will buy your product?
MedCity News has provided the following list of the 10 most sociable healthcare CIOs as a resource to healthcare professionals everywhere:
My organization has 1,032 reports with ICD codes that need to be fixed as part of the ICD10 transition. How about yours?
— Will Weider (@CandidCIO) March 21, 2014
Wearable Computing at BIDMC: Over the past few months, Beth Israel Deaconess has been the pilot site for a new… — John Halamka (@jhalamka) March 12, 2014
Steve Downs (@stephenjdowns) is the CTO and CIO for Robert Wood Johnson Foundation
Steve Huffman (@SteveHuffmanCIO) is the CIO for Beacon Health System
Kevin More (@kmmore) is the CIO for Human Service and Healthcare.org for May Institute, a nonprofit that offers educational, rehabilitative, and behavioral healthcare services to individuals with autism spectrum disorders and other developmental disabilities.
Bill Swavely (@bswavely) is the CIO for BioTelemetry, the company formerly known as CardioNet.
— Bill Swavely (@bswavely) April 2, 2014
David Chou (@dchou1107) is the CIO for the University of Mississippi Medical Center.
53% of clinicians use tablets daily #mhealth
— David Chou (@dchou1107) April 2, 2014
Jay Ferro (@JayFerro) is the CIO for the American Cancer Society.
— Jay Ferro (@jayferro) April 2, 2014
Introducing Dosis - the AI powered dosing platform
Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works.
When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing.
The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced.
What is the Strategic Anemia Advisor?
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease.
SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool.
What else is Dosis working on?
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs.
What are Dosis' strategic goals for the next 2-3 years?
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.
What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.